Christopher Haqq - EVP, Atara Biotherapeutics, Inc

As of February 19, 2019


Christopher Haqq Net Worth

  • Net worth is estimated to be at least $11.5M
  • Owns at least 274,631 units of Atara Biotherapeutics, Inc stock
  • Sold an estimated value of $8.09M in the last 5 years at Atara Biotherapeutics, Inc

Christopher Haqq Trading

  • Largest purchase of shares was 25,000 units , worth over $275K on May 16, 2018
  • Largest sale of shares was 31,500 units , worth over $1.27M on September 25, 2018
  • In total has made about 46 transactions over 5 years
  • Usually trades in February, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christopher Haqq Mailing Address

  • Mailing address is C/o Atara Biotherapeutics, Inc. 3260 Bayshore Boulevard Brisbane CA 94005 CA

Atara Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Pascal Touchon, D.V.M. 2020 $654,857 $422,500 $2,235,600 $1,959,208 $13,662 $5,285,827
Pascal Touchon, D.V.M. 2019 $319,327 $334,791 $2,861,712 $3,049,718 $71,760 $6,637,307
Jakob Dupont, M.D. 2020 $319,231 $143,346 $443,075 $1,757,296 $133,297 $2,796,245
Utpal Koppikar 2020 $460,947 $187,032 $885,431 $597,073 $7,470 $2,137,953
Utpal Koppikar 2019 $439,875 $155,606 $1,034,714 $909,080 $895 $2,540,170
Utpal Koppikar 2018 $240,289 $189,771 $1,903,500 $1,886,325 $398 $4,220,282
Joseph Newell 2020 $466,055 $203,435 $1,033,965 $566,713 $895 $2,251,063
Joseph Newell 2019 $390,000 $155,208 $1,240,675 $932,390 $895 $2,719,167
Joseph Newell 2018 $365,000 $155,490 $895,000 $1,060,710 $16,092 $2,492,292
Kristin Yarema, Ph.D. 2020 $368,308 $147,995 $668,250 $1,067,484 $184,370 $2,436,407
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm

Atara Biotherapeutics, Inc Insider Trading

  • The most recent transaction was 3,116 units sold on September 17, 2021 by Joe Newell worth over $48.65K
  • In the last 7 years, insiders at Atara Biotherapeutics, Inc sold an estimated value of $71.27M and bought an estimated value of $10.11M
  • The most active traders are Isaac E Ciechanover, Chief Executive Officer,  Christopher Haqq, EVP,  and Joe Newell, Chief Operations Officer
  • Insider trading is most common in February, with the busiest year in 2018

Atara Biotherapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1